Medicare Enrolled
Dr. Deven Bhachawat, MD
Optician · San Antonio, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bhachawat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhachawat?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bhachawat
Dr. Deven Bhachawat is an optician specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bhachawat performed 1,605 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bhachawat received a total of $6,069 from 55 pharmaceutical and/or device companies across 280 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhachawat is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 39% volume in TX
$6,069 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,605
Medicare services
Top 39% in TX for optician
Not available
Unique patients (not deduplicated)
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
470 | $61 | $310 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
407 | $91 | $550 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
263 | $1 | $6 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
247 | $135 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
74 | $133 | $660 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
70 | $64 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
58 | $94 | $350 |
| New patient office visit, complex (60-74 min) | 16 | $163 | $660 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
16.4% high complexity
0.0% medium
83.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,069
Total received (2018-2024)
Avg $867/year across 7 years
Top 24% in TX for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
280
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,918
2023
$934
2022
$1,027
2021
$275
2020
$179
2019
$1,037
2018
$698
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$146
Blueprint Medicines Corporation
$140
PharmaEssentia USA Corporation
$131
Astellas Pharma US Inc
$104
PFIZER INC.
$94
Exelixis Inc.
$94
GENZYME CORPORATION
$84
Janssen Biotech, Inc.
$78
RECORDATI_RARE_DISEASES_INC.
$71
SANOFI-AVENTIS U.S. LLC
$70
Genentech USA, Inc.
$64
ARRAY BIOPHARMA INC
$59
Merck Sharp & Dohme LLC
$59
Alexion Pharmaceuticals, Inc.
$55
GlaxoSmithKline, LLC.
$48
E.R. Squibb & Sons, L.L.C.
$46
SOBI, INC
$45
Daiichi Sankyo Inc.
$40
Incyte Corporation
$39
Agios Pharmaceuticals, Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$30
Eisai Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$28
Sumitomo Pharma America, Inc.
$27
Deciphera Pharmaceuticals Inc.
$27
Aveo Pharmaceuticals, Inc.
$26
ABBVIE INC.
$26
TAIHO ONCOLOGY, INC.
$26
Azurity Pharmaceuticals, Inc.
$24
Ipsen Biopharmaceuticals, Inc
$23
Fennec Pharmaceuticals, Inc.
$23
Celgene Corporation
$22
Rigel Pharmaceuticals, Inc.
$22
Karyopharm Therapeutics Inc.
$22
Pharmacosmos Therapeutics Inc.
$18
Janssen Pharmaceuticals, Inc
$17
Lilly USA, LLC
$15
ADC Therapeutics America, Inc.
$13
Top 3 companies account for 21.8% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$790
Novartis Pharmaceuticals Corporation
$658
AstraZeneca Pharmaceuticals LP
$469
PFIZER INC.
$404
Janssen Biotech, Inc.
$326
PharmaEssentia USA Corporation
$268
Boehringer Ingelheim Pharmaceuticals, Inc.
$240
GENZYME CORPORATION
$233
SANOFI-AVENTIS U.S. LLC
$170
Blueprint Medicines Corporation
$140
Incyte Corporation
$121
Exelixis Inc.
$120
Celgene Corporation
$120
Alexion Pharmaceuticals, Inc.
$116
Merck Sharp & Dohme LLC
$113
Astellas Pharma US Inc
$104
Janssen Pharmaceuticals, Inc
$103
ARRAY BIOPHARMA INC
$99
GlaxoSmithKline, LLC.
$96
SOBI, INC
$90
Takeda Pharmaceuticals U.S.A., Inc.
$87
Global Blood Therapeutics, Inc.
$82
RECORDATI_RARE_DISEASES_INC.
$71
Eisai Inc.
$67
Genentech USA, Inc.
$64
Rigel Pharmaceuticals, Inc.
$63
Gilead Sciences, Inc.
$61
Bayer Healthcare Pharmaceuticals Inc.
$51
Merck Sharp & Dohme Corporation
$49
Shield Therapeutics Inc
$49
Sobi, Inc
$48
Amgen Inc.
$44
Daiichi Sankyo Inc.
$40
Octapharma USA, Inc.
$35
Agios Pharmaceuticals, Inc.
$35
Lilly USA, LLC
$33
Teva Pharmaceuticals USA, Inc.
$29
Sumitomo Pharma America, Inc.
$27
Deciphera Pharmaceuticals Inc.
$27
Jazz Pharmaceuticals Inc.
$26
Aveo Pharmaceuticals, Inc.
$26
ABBVIE INC.
$26
TAIHO ONCOLOGY, INC.
$26
Azurity Pharmaceuticals, Inc.
$24
Ipsen Biopharmaceuticals, Inc
$23
Taiho Oncology, Inc.
$23
Fennec Pharmaceuticals, Inc.
$23
Karyopharm Therapeutics Inc.
$22
Pharmacosmos Therapeutics Inc.
$18
TESARO, Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$16
Medtronic USA, Inc.
$16
Dova Pharmaceuticals
$15
ADC Therapeutics America, Inc.
$13
AMAG Pharmaceuticals, Inc.
$11
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ALIMTA · AYVAKIT · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · CABLIVI · CABOMETYX · CALQUENCE · COSELA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ERLEADA · Enhertu · Erleada · FARXIGA · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · LOKELMA · LONSURF · LYNPARZA · Lenvima · MEKINIST · MYLOTARG · NINLARO · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · Onivyde · PIQRAY · PLUVICTO · PROMACTA · Pedmark · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SPRYCEL · SYLVANT · SYNAGIS · Stivarga · TAGRISSO · TASIGNA · TECVAYLI · TIVDAK · Tavalisse · Tecentriq · ULTOMIRIS · VENCLEXTA · VERZENIO · VIVIMUSTA · VOTRIENT · Vectibix · XALKORI · XARELTO · XPOVIO · Xospata · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
190
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
BAPTIST MEDICAL CENTER
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bhachawat is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bhachawat experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Bhachawat performed 470 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bhachawat receive payments from pharmaceutical companies?
Yes. Dr. Bhachawat received a total of $6,069 from 55 companies across 280 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhachawat's costs compare to other opticians in San Antonio?
Dr. Bhachawat's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhachawat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in San Antonio
Browse opticians in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology